期刊文献+

肺癌肝转移外科治疗 被引量:4

Surgical treatment of hepatic metastases of lung cancer
原文传递
导出
摘要 肝脏是肺癌的常见转移部位,在结直肠癌和胃癌病人的肝转移中,较多病例为单独肝脏转移,而肺癌伴肝转移的病人多伴有其他脏器的转移,<1/3的病人仅出现肝转移。目前,对于结直肠癌和神经内分泌肿瘤的肝转移行积极手术治疗已达成共识,但对于肺癌肝转移的手术治疗意见尚不统一。近年来随着肝脏手术技术的进步及对肿瘤生物学特性的认识,肺癌肝转移病人接受手术治疗逐渐增多,且部分病人经手术治疗后可获得长期生存。因此,近年来对于肺癌肝转移的治疗逐渐偏向积极。 Lung cancer metastasis to the liver indicates a poor prognosis, and the majority of patients with metastatic disease to the liver are not indicated for surgery because of the number or diffuse distribution of metastases or the presence of extrahepatic diseases. Liver resection for metastati.e lesions has largely been performed tor secondary eoloreetal or neuroendoerine tumors, and there is little information about its value for lung cancer. Recent improvements in hepatic surgery have made resection of metastases a safe proeedure and it should certainly be considered whenever there is an isolated lesion. More recent reports reinforce the value of an aggressive approach in favorable cases.
出处 《中国实用外科杂志》 CSCD 北大核心 2011年第11期1015-1017,共3页 Chinese Journal of Practical Surgery
关键词 肺癌 肝转移 lung cancer hepatic metastasis
  • 相关文献

参考文献8

  • 1Jemal A, Bray F, Center MM,et al. Global cancer statistics [J]. CA Cancer J Clin, 2011,61 (2):69-90.
  • 2Miyaaki H, Iehikawa T, Taura N, et al. Diffuse liver melastasis of small cell lung eaneer causing marked hepatomegaly and fulmi- nant hepalie failure [ J ]. Intern Med, 2010,49(14): 1383-1386.
  • 3Kadowaki T, Hamada H, Yokoyama A, et al. Hemoperitoneum secondm7 lo sponlaneous rupture of hepatic metastasis from hmg cancer[J ]. Intern Med, 2005, 44(4): 290-293.
  • 4Ogawa R, Kodama T, Kurishima K. Portal vein tumor lhrombus of liver metastasis from lung cancer [J~. Acta Medica (HradecKralove), 2009,52(4): 163-1.66.
  • 5Nagashima A, Abe Y, Yamada S,et al. Long-term survival after surgical reseelion of liver metaslasis from hmg eaneer[J]. Jpn J Thorae Cardiovase Surg, 2004, 52(6):311-313.
  • 6Ercolani G, Grazi GL, Ravaio/i M,et al. The role of liver resec- tions for noneoloreelal, nonneuroendocrine metastases: experi- ence with 142 observed cases[J]. Ann Surg Oneol, 2005, 12(5) 459-466.
  • 7Ileana E, Greillier L, Moutardier V,et al. Surgical resection of liver non-small cell lung cancer metastasis: a dual weapon? [J]. Lung Cancer, 2010, 70(2):221-222.
  • 8Gillams AR, Lees WR. Radio-frequency ablation of coloreetal liver melastases in 167 patienls[J].Eur Radiol, 2004, 14(12): 2261-2267.

同被引文献37

  • 1李勇,张嵘,梁碧玲,元建鹏,叶瑞心,钟镜联.肝转移瘤的MRI类型及少见类型的特征[J].癌症,2006,25(2):212-216. 被引量:7
  • 2Haddadin S, Perry MC. History of small-cell lung cancer[J]. Clin Lung Cancer, 2011, 12(2):87-93.
  • 3Eekmarm K, Michaud LB, Rivera E, et al. Pilot study to assess toxicity and pharmacokinetics of docetaxel in patients with metastatic breast cancer and impaired liver function secondary to hepatic metastases[J]. J Oncol Pharm Pract, 2013 May 14. [Epub ahead of print]. PMID:23676510.
  • 4Neal JW, Gubens MA, Wakelee HA. Current management of small cell lung cancer[J]. Clin Chest Med, 2011(32):53-63.
  • 5Nakazawa K, Kurishima K, Tamura T, et al. Specific organ metastases and survival in small cell lung cancer[J]. Oneol Lett, 2012, 4(4): 617-620.
  • 6Wu C, Li F, Jiao SC. Prognostic factors for survival of patients with extensive stage small cell lung cancer-a retrospective single institution analysis[J]. Asian Pac J Cancer Prey, 2012, 13(10): 4959-4962.
  • 7Kagohashi K, Satoh H, IshikaWa H, et al. Liver mstasis t the time of initial diagnosis of lung cancer[J]. Med Oncol, 2003, 20(1): 25-28.
  • 8Miyaaki H, Ichikawa T, Taura N, et al. Diffuse liver metastasis of small cell lung cancer causing marked hepatomegaly and fulminant hepatic failure[J]. Intern Med, 2010, 49(14):1383-1386.
  • 9Lara PN Jr, Chansky K, Shibata T, et al. Common arm comparative outcomes analysis of phase 3 trials of cisplatin + irinotecan versus cisplatin + etoposide in extensive stage small cell lung cancer: final patient-level results from Japan Clinical Oncology Group 9511 and Southwest Oncology Group 0124[J]. Cancer, 2010,116(24): 5710-5715.
  • 10Rossi A, Di Maio M, Chiodini P, et al. Carboplatin- or cisplatin- based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS Meta-analysis of individual patient data[J]. J Clin Oncol, 2012, 30(14): 1692-1698.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部